The Pharmacy and Drugs Act, 2001

ACT Supplement to the Sierra Leone Gazette Vol. CXXXII, No. 58 dated 13th December, 2001 THE PHARMACY AND DRUGS ACT, 2001 ARRANGEMENT OF SECTIONS Section PART I—PRELIMINARY ENACTED by the President and Members of Parliament in this present Parliament assembled. 2 No. 12 Pharmacy and Drugs Act 2001 PART I—PRELIMINARY [Margin: Interpretation]

"authorized pharmacopoeia" means the latest edition of United States Pharmacopoeia, British Pharmacopoeia, or European Pharmacopoeia; or International Pharmacopoeia; "Board" means the Pharmacy Board established by Section 2; "Class A drug" means a drug listed in Class A in the First Schedule to be sold or dispensed only by a pharmacist; "Class B drug" means a drug listed in Class B in the First Schedule to be sold or dispensed through pharmacies or drug stores; "Class C drug" means a drug listed in Class C in the First Schedule to be sold or dispensed through pharmacies or drug stores or patent medicine stores; "controlled cosmetic" means any cosmetic found to contain any drug which is listed in the First Schedule which may be dispensed only by a pharmacist or pharmacy technician, as the case may be; "cosmetic" means any substance or preparation intended to be applied to any part of the external surface of the human body (i.e.. hair, epidermis, nails, lips and external genital organs) or to the teeth or bucal or other mucosa wholly or mainly for the purpose of clearing, perfuming or protecting or keeping the parts in good condition or changing their appearance, or combating body odour or perspiration; "descriptive matter" means any statement, (whether written or oral) which purports to describe the composition or effect of any drug or reference to application of descriptive matter by way of advertisement on, or with the container in which the drug is supplied or in any other manner; "disease" includes injury and bodily or mental deficiency or abnormality; No. 12 Pharmacy and Drugs Act 2001 3 "pharmacy technician" means a person registered in the Register of Pharmacy Technicians; "drug" means any substance or preparation used or intended to be used for internal or external application to the human or animal body either in the treatment or prevention of disease or for improving physiological functions and it includes nutritional agents and cosmetics; "drug store" means a store licensed under this Act for the sale or supply of Class B and C drugs; "health center" means a medical institution which is maintained by a Government Department, local authority or mission for the treatment of outpatients, and which is under the immediate supervision of an attendant approved by the Board; "Indian hemp" includes the dried flowering or fruiting tops of the pistillate plant known as *cannabis sativa or cannabis indica* from which the resin has been extracted, by whatever name such tops are called, resins from the base, and all extracts or tinctures obtained from such tops; "licensed body corporate" means a body corporate licensed under this Act; "medical institution" means a hospital, clinic, nursing home, or other institution at which human disease is treated; "Minister" means the Minister charged with responsibility for matters relating to health; "narcotic" means, subject to the provisions of section 64, a substance included in Part II of Class A in the First Schedule or a preparation containing any substance referred to in subsection (4) thereof; "nutritional agent" means the principal constituents of food substances, including amino acids, carbohydrates, fixed oils, trace elements, sweeteners, vitamins, alcohol, electrolytes, iron compounds and other substances with nutritional or medical value as listed in the First Schedule; 4 No. 12 Pharmacy and Drugs Act 2001 "patent medicines seller" means a person licensed to sell Class C drugs only; "pharmacist" means a person holding a current certificate of registration issued under this Act, not being a suspended certificate; "pharmacy" means any premises employed under this Act for the carrying on of pharmacy business; "pharmacy business" includes a business which involves the sale of Class A, B and C drugs; "prescribed" means prescribed by regulations made under this Act; "process of manufacture" means a process involving extraction, isolation, synthesizing, formulation or compounding a medical product or drug intended for human consumption or animal consumption; "proprietary drug" means a drug distributed for sale by retail under a brand name or other proprietary description and in a form ready for use; "Registrar" means the person appointed Registrar under Section 6; "speciality" means— (a) a simple drug which is not in the authorized pharmacopoeia; (b) a compound drug which contains any drug which is not in the authorized pharmacopoeia; or (c) a compound drug which contains no drug which is not in the authorized pharmacopoeia but which is compounded on a formula which is not in the authorized pharmacopoeia and was not, to the knowledge of the person wishing to manufacture, import or register the compound drug, in use in Sierra Leone immediately before the commencement of this Act. [illegible] 12 Pharmacy and Drugs Act 2001 5 PART II—THE PHARMACY BOARD [Margin: Establishment of Pharmacy Board.]

(a) the Director of Drugs and Medical Supplies, who shall be the Chairman; (b) a legal practitioner appointed by the Attorney-General and Minister of Justice on the recommendation of the Sierra Leone Bar Association; (c) a pharmacist registered with the Pharmaceutical Society of Sierra Leone; appointed by the Faculty of Pharmaceutical Sciences; (d) two members of the public appointed by the Minister on the recommendation of the Director of Drugs and Medical Supplies; (e) a pharmacist appointed by the Minister on the nomination of the Pharmaceutical Society of Sierra Leone; (f) the President of the Pharmaceutical Society of Sierra Leone; (g) the Secretary General of the Pharmaceutical Society of Sierra Leone; and (h) a pharmacy technician appointed by the Pharmacy Technicians Cadre: Provided that no pharmacist or pharmacy technician shall be appointed to be a member of the Board who has not attained ten years post-registration experience in Sierra Leone. (2) The term of office of appointed members of the Board shall be three years, and the powers of the Board may be exercised notwithstanding a vacancy in its membership. (3) Five members of the Board shall form a quorum, three of whom shall be pharmacists. (4) In the absence of the Chairman at any meeting of the Board, the members present at that meeting shall elect a chairman from among the pharmacists present. 6 No. 12 Pharmacy and Drugs Act 2001 [Margin: Disciplinary Committee.]

For the purpose of advising the Board on matters relating to the professional conduct of pharmacists, pharmacy technicians and other persons engaged in pharmacy business, there shall be a Committee of the Board known as "the Disciplinary Committee" consisting of the following— (a) a legal practitioner, appointed by the Attorney-General and Minister of Justice, who shall be the Chairman; (b) a pharmacist appointed by the Board from among its remaining members; and (c) the Director of Drugs and Medical Supplies. [Margin: Drugs Committee.]

For the purpose of advising the Board on the classification of drugs for the purposes of this Act, there shall be a Committee of the Board known as the "Drugs and Quality Assurance Committee" consisting of the following— (a) the Director of Drugs and Medical Supplies, who shall be Chairman; (b) the Dean of the Faculty of Pharmaceutical Sciences or his representative who shall be a pharmacist; and (c) any two pharmacists who are members of the Board selected by the Board from time to time. [Margin: Education Committee.]

For the purpose of advising the Board on the training of pharmacists and pharmacy technicians for the purposes of this Act, there shall be a committee of the Board known as the "Education Committee" consisting of the following— (a) the Dean of the Faculty of Pharmaceutical Sciences or his representative, who shall be the Chairman; (b) the Registrar; and (c) the President of the Pharmaceutical Society of Sierra Leone or his representative. [Margin: Registrar.]

(1) The Board shall have a Registrar who shall be a pharmacist appointed by the Public Service Commission and shall be the chief administrator and secretary to the Board. (2) The Registrar shall perform such duties as may be required of him under this Act or by the Board. No. 12 Pharmacy and Drugs Act 2001 7 [Margin: Inquires.]

(1) The Chairman of the Board, by summons under his hand, may require any person to appear before the Board at any inquiry held in connection with any of the functions of the Board. (2) A summons under this section may require the person to whom the summons is directed to produce to the Board any documents or other articles under his control, which relate to the matter in question at the inquiry. (3) A person appearing in response to a summons under this section— (a) may be examined as a witness on oath or otherwise; or (b) may examine witnesses and address the Board either himself or by a legal practitioner representing him. (4) Nothing in this section shall require a person to give any evidence or produce any article which would tend to incriminate him. PART III—REGULATION OF PHARMACY PROFESSION [Margin: General responsibility of Pharmacy Board.]

The Board is charged with general responsibilities for securing the highest practicable standards in the practice of pharmacy in Sierra Leone by promoting proper training and examination of pharmacy students, by controlling the registration of pharmacists and pharmacy technicians and premises where such business is carried on and by any other means within the powers conferred by this Act. [Margin: Training for pharmacists and pharmacy technicians.]

(a) prescribe courses of instruction and practical training for pharmacy students; and (b) provide for the examination in pharmacy practice of qualified pharmacists from recognized institutions who have completed internship training in Sierra Leone and who have paid the prescribed fee. (2) This section applies to the training of pharmacy technicians as it applies to the training of pharmacists subject to such modifications as the Minister may prescribe. 8 No. 12 Pharmacy and Drugs Act 2001 [Margin: Registration of pharmacists and pharmacy technicians.]

(2) The Registrar shall also make and keep in the prescribed form a Register of Pharmacy Technicians. (3) If an application is made in the prescribed manner by an individual, and the Board is satisfied that the applicant— (a) is of good character; (b) holds a degree, diploma or other qualification denoting a standard which in the opinion of the Board is not lower than that required for registration as a pharmacist; and (c) has completed twelve months of internship under the supervision of a pharmacist accredited by the Board for this purpose and passed the prescribed examination, the Board shall direct the Registrar to enter the name of the applicant in the Register of Pharmacists and to issue him a certificate of registration in the prescribed form. (4) The Board may also cause the Registrar to register in the Register of Pharmacy Technicians the name of an applicant and to issue him a certificate of such registration in the prescribed form where the Pharmacy Board is satisfied that the applicant— (a) is of good character; (b) holds a diploma or other qualification denoting a standard, which, in the opinion of the Board, is not lower than that required for registration as a pharmacy technician; and (c) has completed twelve months' internship under the supervision of a pharmacist or registered pharmacy technician accredited by the Board for this purpose and has passed the examination prescribed by the Board. No. 12 Pharmacy and Drugs Act 2001 9 (5) A person whose name has previously been entered in the Register of Pharmacists or the Register of Pharmacy Technicians shall not make an application for registration under this section, if— (a) his certificate of registration is cancelled under section 13 and a period of two years has not elapsed since notice of the cancellation was published in the Gazette; or (b) his certificate is suspended. [Margin: Membership of Pharmaceutical Society.]

(1) When a person's name is entered in the Register of Pharmacists that person shall thereupon be regarded as a member of the Pharmaceutical Society of Sierra Leone. (2) If a pharmacist ceases to be a member of the Pharmaceutical Society, the Society shall notify the Board which shall order the certificate of registration of the pharmacist to be cancelled. [Margin: Disciplinary proceedings.]

(1) Where a complaint is made to the Registrar, or the Registrar has reason to believe, that any of the following events has occurred in relation to a pharmacist, pharmacy technician or to any person engaged in pharmacy business namely— (a) that he has committed an offence under this Act; or (b) that he has been accused of professional misconduct, the Registrar shall take such steps as are practicable to verify the occurrence; and if in his opinion there is cause for an inquiry by the Disciplinary Committee, he shall serve a notice to that effect on the pharmacist, pharmacy technician or the person engaged in pharmacy business and invite him to furnish in writing within six weeks from the date of the notice such explanation as he may desire to make. 10 No. 12 Pharmacy and Drugs Act 2001 (2) Where the Registrar has served notice on a person under subsection (1) , he shall lay a copy of the notice together with any explanation furnished by the pharmacist, pharmacy technician or person engaged in pharmacy business and all other relevant documents, before the Disciplinary Committee. (3) If the Disciplinary Committee, after considering the explanation (if any) furnished by the person, is also of the opinion that there is cause for an inquiry, it shall order an inquiry to be held. (4) If the Disciplinary Committee, after an inquiry under this section is satisfied that an event specified in subsection (1) and alleged against the pharmacist, pharmacy technician or person engaged in pharmacy business has occurred it may make any one or more of the following recommendations to the Pharmacy Board: (a) that the pharmacist, pharmacy technician or person engaged in pharmacy business be reprimanded by the Board; (b) that the pharmacist, pharmacy technician, or person engaged in pharmacy business be required to pay to the Board a fine not exceeding five hundred thousand Leones; (c) that the certificate of registration of the pharmacist, pharmacy technician or person engaged in pharmacy business or licence of the body corporate be cancelled and premises closed. (5) The Disciplinary Committee may also recommend that any party to the proceedings at the inquiry be ordered by the Board to pay the whole or part of the costs of any other party. (6) On receiving a recommendation of the Disciplinary Committee under this section, the Board may, by order, implement the recommendation or remit the recommendation to the Disciplinary Committee for further consideration. No. 12 Pharmacy and Drugs Act 2001 11 (7) Where a notice under subsection (1) has been served on a pharmacist, pharmacy technician, or person engaged in pharmacy business, the Board may order that the certificate of registration of the pharmacist or pharmacy technician be suspended, until the conclusion of the proceedings against him. [Margin: Cancellation and suspension of registration.]

(1) Where a certificate of registration of a pharmacist or pharmacy technician is ordered to be cancelled or suspended, the Registrar— (a) shall serve on the pharmacist or pharmacy technician a notice informing him of the order and requiring him to deliver up the certificate within twenty-one days after the date of service of the notice; (b) shall cause notice of the cancellation or suspension to be published in the Gazette; and (c) in the case of cancellation, shall delete the name of the pharmacist or pharmacy technician from the Register of Pharmacists, or the Register of Pharmacy Technicians. (2) Where, in pursuance of the recommendation of the Disciplinary Committee under this section, the Board has ordered the certificate of registration of a pharmacist or pharmacy technician to be cancelled or suspended, the pharmacist or pharmacy technician may appeal within twenty-one days to the High Court against that order. (3) Upon an appeal under subsection (2), the High Court may confirm, reverse or vary the order and may make such other order as it may think just. (4) Any person whose name has been temporarily removed from the Register of Pharmacists or Register of Pharmacy Technicians shall be entitled, on the expiration of the period of removal, to have his name restored to the Register of Pharmacist or Register of Pharmacy Technicians as the case may be. 12 No. 12 Pharmacy and Drugs Act 2001 (5) When a period of suspension of the certificate of registration of a pharmacist or pharmacy technician comes to an end, the Registrar:— (a) shall restore the certificate to the pharmacist or pharmacy technician as the case may be, and (b) shall cause notice of the ending of the suspension to be published in the Gazette. [Margin: Annual publication of list of pharmacists and pharmacy technicians.]

The Registrar shall cause a list of all pharmacists and pharmacy technicians whose names appear in the Register of Pharmacists and the Register of Pharmacy Technicians on the 31st day of December in each year to be published in the Gazette during the month of January next following. [Margin: Restriction on use of the words "Pharmacist", etc.]

(1) No person who is not a pharmacist shall describe himself as, or otherwise hold himself out to be, a pharmacist, whether by the use of the term "pharmacist", "pharmaceutical chemist" or any similar term. (2) No person shall cause or permit any premises to open to the public which includes in its name the word or the description "pharmacy", "chemist" or any similar description unless the premises are under the supervision of a registered pharmacist. (3) This section shall not apply to the description "drug store" or "patent medicine dealer" when used by a registered dispensing technician. [Margin: Medical aid by pharmacists and pharmacy technicians.]

(1) Notwithstanding any law which restricts the right to practice medicine or dentistry and recover charges therefrom, a pharmacist or pharmacy technician may give free medical or dental advice or aid— (a) by way of first aid in cases following an accident; or (b) by way of first aid treatment in the case of simple ailments of common occurrence. No. 12 Pharmacy and Drugs Act 2001 13 (2) Where advice or aid is given by a pharmacist or pharmacy technician in accordance with this section nothing shall prevent the recovery by the pharmacist or pharmacy technician of a charge for any medicine or appliance or service supplied by him. PART IV—CONTROL AND SUPPLY OF DRUGS [Margin: Persons entitled to dispense Class A Part I drugs.]

No person shall mix, compound, prepare, supply or shall without reasonable excuse, proof of which shall be on him, possess any Class A Part 1 drug unless that person is a pharmacist, or is a licensed body corporate acting in accordance with section 19: Provided that this section shall not prevent— (i) the mixing, compounding, preparing of any drug by a medical practitioner, dentist or veterinary surgeon, or the supply by any such person of a drug either to a person in urgent need of treatment or from a place more than five miles off from the premises of a pharmacy business; or (ii) the mixing, compounding or preparing of any drug, under the immediate supervision of a pharmacist, dispensing technician or by a student undergoing instruction at an institution approved by the Board; (iii) the supply of drug, in accordance with directions given by a medical practitioner, to an outpatient attending a medical institution. [Margin: Control and supply of Class A Part 1 Classes B and C drugs in a hospital, etc.]

(1) The control and supply of Class A Part 1, Class B and Class C drugs in a hospital or Health Center shall be under the supervision of a pharmacist or pharmacy technician in practice in a hospital approved by the Board. 14 No. 12 Pharmacy and Drugs Act 2001 (2) A Pharmacy Technician in private practice shall only compound, prepare, dispense, sell and retail Classes B and C drugs. (3) No pharmacy business shall be conducted in the same premises housing a private surgery and clinic. (4) This section also applies to non-governmental organizations, parastatals, mission hospitals, corporate bodies and other institutions that handle Classes A, B and C drugs. [Margin: Licensed bodies corporate.]

(a) that the applicant is fit to carry on the business of mixing, compounding, and preparing Class A Part 1, Class B and Class C drugs and supplying such drugs by retail; and (b) that its business, so far as concerns such drugs, will be carried on under the immediate supervision of a pharmacist, the Board may direct the Registrar to issue to the applicant a license authorizing it, subject to this Act and of any conditions specified by direction of the Board in the licence, to carry on such a business, and the Registrar shall, on payment of the prescribed fee, issue the licence accordingly. (2) A license issued under this section shall remain in force until such date as is specified by direction of the Board in the licence: Provided that the Board may revoke the licence if at any time it is satisfied that the body corporate has contravened any of the provisions of this Act or any condition specified in the licence, or is satisfied that the body is no longer fit to carry on such a business. [Margin: Patent medicine and cosmetics sellers.]

(1) The Board may cause to be licensed persons authorized by it to sell or retail any Class C drugs, nutritional agents or related cosmetic products. (2) A person referred to in subsection (1) may use the expression "patent medicine and cosmetic seller" in connection with the sale or retail of Class C drugs, nutritional agents and cosmetic under his licence. No. 12 Pharmacy and Drugs Act 2001 15 (3) This section does not apply to drug peddlers and hawkers. [Margin: Place from which drugs may be supplied.]

(a) if drugs including Class A Part 1 or Class B drugs are supplied, unless either a general or a limited certificate issued under this Act expressly empowers him to do so; or (b) if drugs other than Class A Part 1 and Class B drugs are supplied, unless either a general or a limited certificate under this Act is in force in relation with the premises . (2) No person shall supply any Class A Part 1 or B drugs by means of an automatic machine or from any vehicle of any description. [Margin: Certificate of suitability of premises.]

(1) If, on an application made in the prescribed form for a certificate under this section in relation to any premises, the Board is satisfied that the accommodation, fixtures, equipment and other physical attributes of those premises are such as to render those premises suitable either for the supply of any Class A Part 1 or Class B only or for the supply Class A Part I and Classes B and C drugs, the Board shall direct the Registrar to issue in respect of those premises, either a general certificate or a limited certificate, as the case may be; and the Registrar shall, on payment of the prescribed fee, issue the certificate accordingly. (2) Every person carrying a business of supplying Class A Part 1 and Class B drugs from premises in respect of which a certificate issued under this section is in force shall forthwith notify the Board of any material alteration in the physical attributes of the premises or, if no such alteration occurs in any calendar year, shall notify the Board of that fact before the end of January in the following year. (3) A certificate issued under this section shall remain in force until such date as is specified by direction of the Board in the certificate, but the Board may revoke the certificate, at any time it is satisfied that owing to an alteration or deterioration in the physical attributes of the premises, it has ceased to be suitable for the supply of all or any of the drugs referred to in subsection (1). 16 No. 12 Pharmacy and Drugs Act 2001 (4) The Registrar shall keep a register of all premises to which certificates have been issued under this section. (5) The Registrar shall publish annually in the Gazette, a list of all pharmacies and drug stores. [Margin: Need for prescription.]

(1) A pharmacist or pharmacy technician, as the case may be, or a body corporate shall not supply a Class A Part 1 or Class B drug, otherwise than under a prescription reasonably believed by the person supplying the drugs to be valid— (a) if the drug is supplied under a signed order to a medical practitioner, dentist, veterinary surgeon, pharmacist or licensed body corporate for the purpose of being subsequently dispensed or supplied; or (b) if the drug is supplied from the dispensing department of a medical institution approved for the purposes of this section by the Board and is for general use in the wards, operating theatre or other sections of the institution; or (c) if the drug is supplied, in accordance with directions given by a medical practitioner, to an out-patient attending a medical center. (2) A prescription is valid if— (a) it is in indelible writing, is dated and is signed with his usual signature by a medical practitioner, dentist or veterinary surgeon; and (b) it states the name, qualification and address of the person signing it; and (c) it states the name and address of the person for whose treatment it is given or, if signed by a veterinary surgeon, the person to whom the drug is prescribed is to be delivered; and No. 12 Pharmacy and Drugs Act 2001 17 (d) if signed by a dentist, it bears the words "for dental treatment" or, if signed by a veterinary surgeon, it bears the words "for animal treatment only"; and (e) it indicates the form of the drug to be supplied, and the amount of the drug to be supplied and the dose to be taken; and (f) it has not previously been fully dispensed. (3) A prescription is fully dispensed— (a) where it does not state that it may be dispensed more than once, after the amount of drug prescribed has been supplied once; or (b) where it states that it may be dispensed a certain number of times, after the drug prescribed has been supplied that number of times; or (c) where it states that it may be dispensed at intervals but does not state the number of times, after the drug prescribed has been supplied three times. (4) A Class A Part 1 and Class B drug shall not be supplied a second or subsequent time under a prescription which states that it may be dispensed at unspecified intervals unless the person supplying the drug reasonably believes that a reasonable time has elapsed since the drug was previously supplied under the prescription. [Margin: Action to be taken in relation to prescription]

(a) the person supplying the drug shall enter on the prescription in indelible writing the date on which it is supplied and the name and address of the supplier; 18 No. 12 Pharmacy and Drugs Act 2001 (b) if the prescription is fully dispensed, it shall be retained by the supplier, and, shall be kept in the premises at which it was dispensed for a period of two years in such a manner as to be readily available for inspection. [Margin: Class 'A' Part 1 or 'B' drug to be properly supplied.]

A pharmacist or pharmacy technician or licensed body corporate shall not supply a Class A Part 1 or Class B drug to any person other than a person who is reasonably believed by the supplier to be a person to whom the drug may properly be supplied. [Margin: Drug to conform to prescription or order.]

No person shall supply any Class A or Class B drug which does not conform to the prescription or order under which it is supplied. [Margin: Prescription book and Narcotic Register.]

(1) Every person who supplies Class A or Class B drugs or both shall keep in all premises from which such drugs are supplied by him, a prescription book, and in addition, where he supplies Class A Part II drugs, a Narcotic Register. (2) Before any person supplies a Class "A" Part II drug he shall enter or cause to be entered in the Narcotic Register, the following: (a) name and address of prescriber; (b) the name and quantity of the drug to be supplied; (c) the name, address and signature of the person to whom it is about to be delivered; (d) the signature of the person who is about to deliver the drug; and (e) the date of the delivery: Provided that, if the drug is supplied under a prescription which is retained by the supplier and an entry is made in the Narcotic Register, enabling the prescription to be referred to, no entry need be made in the book of any particulars specified in the prescription. No. 12 Pharmacy and Drugs Act 2001 19 [Margin: Containers and labels.]

(a) it is in a container of the prescribed description; and (b) the container bears a label giving the prescribed particulars of its contents. [Margin: Further restriction on supply of narcotics.]

(1) The Minister, acting on the advice of the Board, may make regulations further restricting the person who may supply narcotics, and otherwise controlling the supply of such drugs. (2) No person shall supply any opium or Indian hemp of any species or description whatsoever. [Margin: Possession of narcotics prohibited.]

No person shall, without lawful excuse, proof of which shall be on him, have any narcotic to which subsection (1) of section 48 applies. DRUGS GENERALLY [Margin: Duty to supply drugs.]

If a person carrying on or employed in a pharmacy business is requested during normal business hours to dispense a valid prescription, or to supply any drug to a medical practitioner or dentist for use in immediate treatment, he shall comply with the request unless there are reasonable grounds for his failing to do so. [Margin: Impure drugs not to be supplied.]

(1) No person shall knowingly supply any drugs which is unfit for its purpose by reason of deterioration, impurity, adulteration or other defects. (2) No person shall supply any drug unless it meets the standards stipulated in the authorized pharmacopoeia and approved by a quality control laboratory appointed by the Board. [Margin: Power to call for information.]

(1) Where the Board has reason to believe that any person is proposing to sell any proprietary drug by retail or to procure (whether directly or indirectly), its sale by retail, it may require that person to furnish it with:— 20 No. 12 Pharmacy and Drugs Act 2001 (a) details of the composition of the drug, and (b) copies of any descriptive matter published or proposed to be published in relation to the drug. (2) No disclosure of information furnished under this section shall be made without the consent of the person by whom it was furnished. [Margin: Power to prohibit sale of proprietary drug.]

(a) claims are made for the drugs which are unjustified; or (b) details of the composition of the drug furnished under this Act differ substantially from those disclosed on an analysis of samples by a laboratory approved by the Board. (2) Descriptive matter published in relation to a proprietary drug must be in English and should not differ substantially from that contained in copies furnished to the Board in relation to the drug under section 33 and the Board may prohibit the sale of any drug, in respect of which it is satisfied that this subsection has not been complied with. [Margin: Control of publication of descriptive matter.]

(1) Subject to this section, no person shall, by way of advertisement, publish or cause to be published in relation to any drug or service, descriptive matter calculated to lead to the use of that drug or service:— (a) for the prevention or treatment of any disease specified in the Second Schedule; or (b) for the purpose of terminating or influencing the course of human pregnancy; or (c) for any purpose relating to human sexual intercourse. No. 12 Pharmacy and Drugs Act 2001 21 (2) Subject to this section, the Board may, with the approval of the Minister, serve on any person a notice prohibiting him from publishing in relation to any drug descriptive matter referred to in the notice. (3) No person shall in any way advertise any drug, dressing or appliance except with the approval of the Board. (4) This section does not apply to the publication of descriptive matter— (a) by direction of the Board; or (b) in a document intended for persons whose profession or employment calls for a knowledge either of drugs generally or of drugs of the description to which the matter in question is related; or (c) for the purpose of an application for the grant of a patent. [Margin: Return of details of pharmacy business.]

(1) Every person intending to start a new pharmacy business or transfer to a new location must send to the Registrar a return in the prescribed form not less than thirty days before commencement of business or transfer, as the case may be. (2) Every person carrying on a pharmacy business on any premises shall annually in the month of January send to the Registrar a return in the prescribed form stating— (a) the location and postal address of the premises; (b) the name and principal postal address of the person carrying on the business; (c) the name of the pharmacist or pharmacy technician carrying on the pharmacy business or supervising the sale of drugs at the premises. 22 No. 12 Pharmacy and Drugs Act 2001 (3) If any alteration occurs in the particulars stated in the last return made under this section, the person carrying on the business shall, within twenty-one days thereafter send to the Registrar notice in writing of the alteration. [Margin: Wholesale supply.]

No person shall carry on the business of supply by wholesale Class 'A' and 'B' drugs unless he employs a pharmacist in a supervisory capacity to ensure legal responsibility in the distribution. [Margin: Licence required for wholesale of Class 'A' and 'B' drugs.]

(1) No person shall carry on a business supplying Classes 'A' and 'B' drugs by wholesale unless he is authorized to carry on that business by a licence granted under this section. (2) The Board may grant a licence for the carrying on of a business of supplying Class A and Class B drugs by wholesale if— (a) an application for the licence is made in the prescribed form and the applicant pays the prescribed fee; and (b) the Minister acting on the advice of the Board is satisfied that the applicant is a person to whom the licence can properly be granted. (3) A licence granted under this section may include a condition prohibiting or limiting the supply of a description specified in the condition, and shall, in any case be deemed to include a condition prohibiting the supply of any opium or Indian hemp which is prepared for smoking . (4) Subject to subsection (5), a licence granted under this section shall remain in force until such date as is specified in the licence. (5) If at any time the Board is satisfied that the holder of the licence has contravened any of the provisions of this Act or any condition contained in the licence, or has ceased to be fit to carry on such a business as aforesaid, then the Board may revoke the licence before its expiration. No. 12 Pharmacy and Drugs Act 2001 23 PART V—CONTROL OF MANUFACTURE AND STORAGE OF DRUGS [Margin: Restriction of manufacture of specialities.]

Provided that this section shall not prevent the manufacture of a sample not exceeding fifty grammes in weight. [Margin: Restriction of manufacture of Classes A and B drugs.]

No person shall manufacture any Class A or B drug unless the processes of manufacture is carried out or supervised by a pharmacist or a person approved by the Board as qualified to carry out or supervise those processes. [Margin: Further restriction on manufacture of narcotics.]

(1) The Minister may make regulations under section 62 further limiting the persons who may manufacture narcotic drugs and the premises in which they may be manufactured, and otherwise controlling their manufacture. (2) No person shall manufacture opium or Indian hemp in a state prepared for smoking. STORAGE [Margin: Requirements as to storage of Class A Part II drugs.]

(1) No person shall store Class A Part II drugs on any premises unless such storage conforms to the specifications as recommended by the Board. (2) Where Class A' Part II drugs are kept on any premises, they shall be kept in accordance with the rules contained in the table set out at the end of this section: Provided that the rules referred to in subsection (2) shall not apply to a drug supplied to an individual for the treatment of himself or another individual residing with him or an animal in his possession or control. (3) If an act is done on any premises in contravention of the rules referred to in the subsection (2) then— 24 No. 12 Pharmacy and Drugs Act 2001 (a) in a case where the act constitutes a breach of a duty imposed by or under the terms of his employment upon a person employed on the premises, that person shall be deemed to be liable for the contravention; (b) in any other case, the occupier of the premises shall be deemed to be liable for the contravention: Provided that nothing in this subsection shall prevent any person who wilfully removes or alters the label on any container, or does any other act (as opposed to an omission), in respect of a restricted drug, from being treated as liable for a contravention of the rules concerned. TABLE (1) The drug shall be kept in a container bearing a label— (a) containing the word 'Narcotic' or the word 'Poison' in bold red letters, or in bold white letters on a red background; and (b) giving the name of the drug. (2) The drug shall be kept in accordance with any directions for the keeping thereof laid down in the authorized pharmacopoeia. (3) The container holding the drug shall be kept in a room, cupboard or drawer— (a) on which nothing except narcotic is kept; and (b) which is securely locked when not in use. PART VI—CONTROL OF TRANSPORT, IMPORT AND EXPORT OF DRUGS TRANSPORT [Margin: Requirement as to transport of Class A Part II drugs]

(1) No person shall consign any Class A Part II drugs for transportation unless it is consigned in a container bearing a label indicating that the container should be kept away from food and from any thing likely to come into contact with food. No. 12 Pharmacy and Drugs Act 2001 25 (2) No person shall carry in any vehicle in which food is being carried, a container bearing a label such as is described in subsection (1) unless— (a) the container is carried in a part of the vehicle effectively separated from the food; (b) the food is otherwise adequately protected from the risk of contamination. (3) In this section 'food' includes anything intended for human or animal consumption. IMPORT AND EXPORT [Margin: Restriction on import of drugs and specialities.]

Provided that this section shall not prevent the importation of a sample not exceeding fifty grammes in weight. [Margin: Restriction on import of Class 'A' and 'B' drugs.]

(a) he is a pharmacist or pharmacy technician or licensed body corporate, as the case may be; (b) he is authorized to import the drug by a lisense granted under section 47 and he complies with the conditions contained in the licence; and (c) the drug is in a container of the prescribed particulars of its content. (2) No medical practitioner, dentist or veterinary surgeon shall import any drug referred to in subsetion (1) except with the approval of the Board. (3) Where a person imports any Class 'A' Part 1 drug, he shall within fourteen days thereafter deliver to the Board the prescribed particulars of the drug imported. 26 No. 12 Pharmacy and Drugs Act 2001 (4) In relation to narcotic drugs, no person shall be authorized to import such drugs except the Director of Drugs and Medical Supplies. [Margin: Restriction on export of Class 'A' Part II drugs.]

No person shall export any narcotic unless he is authorized to export the drug by a licence granted under section 47 and complies with any conditions contained in the licence. [Margin: Import and export.]

(1) The Minister acting on the advice of the Board, may grant a licence for import of a narcotic drug or the export of a narcotic drug if- (a) the application for the licence is made in the prescribed form and the applicant pays the prescribed fee; and (b) the Minister is satisfied that the applicant is a person to whom the licence can properly be granted. (2) No licence shall be granted for the import or export of any opium or Indian hemp which is prepared for smoking. PART VII—FURTHER RESTRICTIONS ON NARCOTICS [Margin: Possession of narcotics.]

(1) No person shall have in his possession without lawful excuse, proof of which shall be on him, any opium or Indian hemp of any species or description whatsoever or any residue thereof. (2) The Minister may under section 62 make regulations applying the provisions of subsection (1) to such narcotics as may be specified in the regulations. [Margin: Smoking of opium or Indian hemp prohibited]

(a) smoke opium or Indian hemp or frequent any place used for the smoking of such drugs; or (b) permit premises owned or occupied by him to be used by any person smoking opium or Indian hemp; or No. 12 Pharmacy and Drugs Act 2001 27 (c) have in his possession pipes or other utensils for use in connection with the smoking of opium or Indian hemp. [Margin: Cultivation of plants yeilding narcotics.]

PART VIII—POWERS OF ENTRY AND INVESTIGATION [Margin: Powers of entry.]

(1) Any person authorized in that behalf by the Board, shall have the power to enter at any reasonable time any of the following premises:— (a) in respect of which a certificate issued under this Act is in force; (b) on which or in relation to which he has reasonable cause to suspect that an offence under this Act has been or is being committed; (c) on which the business relating to the manufacture or supply of narcotic drugs is carried on. (2) Any police officer not below the rank of Assistant Superintendent shall have power to enter at any reasonable time any premises on which or in relation to which he has reasonable cause to suspect that an offence under this Act has been or is being committed. [Margin: Powers of investigation.]

(a) may inspect the premises and any article found therein; (b) may require any person on the premises to furnish any information in his possession as to the activities carried on on the premises and the person by whom they are carried on; and (c) may take away any drug found on the premises. 28 No. 12 *Pharmacy and Drugs Act* 2001 (2) Where a drug is taken under this section, reasonable payment therefor shall be tendered by the inspecting officer except that— (a) no payment need be tendered in respect of a drug if the inspecting officer reasonably suspects that the drug is unfit for its purpose, by reason of deterioration, impurity, adulteration or other defect; but if the drug is found on analysis not to be so unfit, reasonable payment shall be tendered by the inspecting officer in respect of so much of the drug as is not returned to its owner in good condition; (b) no payment need be tendered in respect of a drug if the inspecting officer anticipates that proceedings for an offence under this Act will be brought in respect of the drug; but if such proceedings are not commenced within six months, reasonable payment shall be made by the inspecting officer in respect of so much of the drug as is not returned to its owner in good condition. [Margin: Authority to be known.] **53.** An inspecting officer exercising any powers conferred by this Part shall produce on demand a duly authenticated document showing that he is entitled to exercise those powers. [Margin: Obstructing an officer.] **54.** No person shall obstruct an inspecting officer exercising powers under and in accordance with this Part or fail to comply with a requirement made by him in exercise of those powers. PART IX—MISCELLANEOUS AND SUPPLEMENTARY [Margin: Registration of drugs and specialities.] **55.** (1) The Registrar shall make and keep a register of all drugs and specialities in the prescribed form. (2) If, on an application made in the prescribed manner and on payment of the prescribed fee, the Board is satisfied— (a) that the drug in respect of which the application is made is a speciality and has not previously been registered under this section; and No. 12 *Pharmacy and Drugs Act* 2001 29 (b) that the use of the speciality is likely to prove beneficial, it shall direct the Registrar to enter the name and description of the speciality in the appropiate register and the Registrar shall comply with the direction. (3) Where, on an application so made, the Board is not satisfied as aforesaid, it shall direct the Registrar to notify the applicant that the application is dismissed and the Registrar shall comply with the direction. (4) If, at the expiration of three months from the date on which an application is duly made under this section, the Board has not given a direction under subsection (2) or (3), the Registrar shall thereupon enter the name and description of the speciality in the appropriate register. (5) The register shall at all reasonable times be open for public inspection. [Margin: Cultivation etc. of strophanthus.] **56.** (1) No person shall without the written consent of the Minister, cultivate the plant known as *strophanthus hispidus* A.P.D.C., *strophanthus sarmentosus* A.P.D.C., *Datura Stramonium* and *Datura metel*. (2) No person shall have in his possession without lawful excuse (proof of which shall be on him) any preparation or derivative from either of the plants referred to in subsection (1) or any instrument or weapon treated with such a preparation or derivative. [Margin: Restriction on supply of syringes and needles.] **57.** (1) No person shall supply a syringe or needle designed for intramuscular or intravenous injection to any person other than a medical practitioner, dentist, pharmacist, practicing midwife, nurse or licensed body corporate except under an order signed by a medical practitioner. (2) Subject to this section, no person shall have in his possession without lawful excuse, (proof of which shall be on him) any syringe designed for intramuscular or intravenous injection. 30 No. 12 *Pharmacy and Drugs Act* 2001 [Margin: Erasures in registers and certificates.] **58.** No erasure shall be made in any register or certificate, copy or extract thereof, but if an error shall occur then a line of red ink shall be drawn through any word improperly inserted so as to leave the original word legible, and any word which may have been omitted shall either be interlined or written in the margin with red ink, and the Registrar shall subscribe his name in the margin opposite to such correction. [Margin: Punishment of offence] **59.** (1) A person commits an offence if he acts in such a way as to contravene a requirement, condition or prohibition imposed by or under this Act. (2) A person guilty of an offence under this Act shall be liable— (a) where the offence is related to a narcotic— (i) on conviction on indictment, to a fine not less than twenty-five million leones or to a term of imprisonment not less than twenty years or both; (ii) on summary conviction or to a fine not less than ten million leones or imprisonment for a term not less than ten years; (b) where the offence is that of supply of opium, or Indian hemp or of cultivating Indian hemp contrary to subsection (2) of section 29 or section 50, as the case may be, and in each case the person has been convicted of that offence on two previous occasions, to imprisonment for a term not exceeding thirty years; (c) where the offence is that of smoking or having in his possession any opium or Indian hemp contrary to paragraph (a) of section 49 or to subsection (l) of section 48, as the case may be, and the person had been convicted of that offence on two previous occasions, to imprisonment for a term not exceeding twenty years; No. 12 *Pharmacy and Drugs Act* 2001 31 (d) in any other case, on summary conviction, to a fine not exceeding five million leones, or imprisonment for a term not exceeding two years, or both. (3) Where an individual is convicted of an offence under this Act relating to Indian hemp, he shall be sentenced to imprisonment for a term not less than fifteen years; but nothing in this subsection shall prevent the imposition of a longer term of imprisonment on conviction on indictment. (4) Where proceedings are brought for an offence under this Act— (a) the court may order the forfeiture and destruction or other disposal of any drug in respect of which an offence is found to have been committed; (b) the court shall, in respect of any drug taken from its owner without payment and in respect of which no offence is found to have been committed, order that reasonable payment shall be tendered to the owner in respect of so much of the drug as is not returned to him in good condition. (5) Any person who wilfully procures or attempts to procure, himself to be registered under this Act by making or producing, or causing to be made or produced any false or fraudulent certificate representation or declaration, either verbally or in writing, and any person aiding or assisting him therein, commits an offence and shall, on summary conviction be liable to a fine not exceeding two million leones, or to imprisonment for a term not exceeding ten years or both. (6) Any person who willfully destroys or injures or causes to be destroyed or injured, any register or any part thereof commits an offence and shall be liable on summary conviction to a term of imprisonment not exceeding fifteen years. 32 No. 12 *Pharmacy and Drugs Act* 2001 [Margin: Offence by bodies of persons.] **60.** (1) Where an offence is committed under this Act or under any regulations made thereunder by a body of persons, then — (a) in the case of a body corporate, any person who, at that time of the act constituting the offence was director or officer of that body, shall be deemed to be guilty of that offence; (b) in the case of a firm, every person who at the time of the commission of the act constituting the offence was a partner or officer of that body, shall be deemed to be guilty of that offence. (2) No person shall be liable for an offence by virtue of this section if he proves that the act in respect of which he is charged was committed by some other person without his knowledge or connivance and that he exercised all due diligence to prevent the commission of the offence having regard to all the circumstances. [Margin: Evidence.] **61.** In proceedings under this Act the following shall be *prima facie* evidence of the facts stated therein— (a) a licence or certificate purporting to have been issued under this Act; (b) a document purporting to state the results of an analysis carried out on behalf of the Minister or the Board for the purposes of this Act. [Margin: Power of Minister to make regulations.] **62.** The Minister, acting on the advice of the Board, may make regulations— (a) prescribing anything which under this Act may be prescribed; (b) prescribing conditions to be inserted in licences granted under this Act and otherwise prescribing things to be done in relation to such licences; No. 12 *Pharmacy and Drugs Act* 2001 33 (c) prescribing the procedure to be followed at meetings, inquiries and other proceedings of the Board and its Committees; (d) laying down further conditions as to the storage of, and access to, Class A and Class B drugs; and (e) for any other purpose necessary or expedient for carrying into effect the provisions of this Act. [Margin: Amendment of drug list by Minister.] **63.** The Minister, acting on the advice of the Board, may by statutory instrument make an order to amend the drug classification in the First Schedule. [Margin: Classification of narcotic.] **64.** (1) Subject to this section, the substances mentioned in Class A Part II in the First Schedule are narcotics for the purposes of this Act. (2) If the Minister by order declares that a finding with respect to a preparation of any of the drugs included in Class A Part II of the First Schedule or as may be specified in the order, has been communicated under United Nations Convention on Narcotic Drugs, signed in 1961, the preparation shall, with effect from such date as may be specified in that behalf in the order cease to be a narcotic for the purposes of this Act. (3) If the Minister is at any time satisfied that a product included in Class A Part II of the First Schedule is of medical or scientific value, he may by order direct that the product specified in the order shall cease to be a narcotic drug for the purposes of this Act: Provided that the Minister shall by order revoke the previous order if at any time a decision is communicated under Article II of the United Nations Convention against illicit traffic in narcotic drugs and psychotropic substances signed in 1988, to the effect that the product in question is capable of producing addiction. 34 No. 12 *Pharmacy and Drugs Act* 2001 (4) The Minister may by regulations made under this Act, amend Class A Part II of the First Schedule by inserting an additional substance which is convertible into a drug capable of producing addiction. (5) The Minister may by regulations made under this Act, amend Class A Part II of the First Schedule by inserting an additional substance if— (a) the substance is a new derivative of morphine or cocaine or any salts of morphine or cocaine or any other alkaloid of opium or any other drug of whatever kind; and (b) if in the opinion of the Minister, the substance or substances into which it is capable of being converted is likely to be productive, if improperly used, of effects similar to that produced by morphine or cocaine. [Margin: Dangerous Drugs Act. (Cap 154) to remain.] **65.** This Act shall have effect without prejudice to the provisions of the Dangerous Drugs Act. [Margin: Repeal of Act No. 1 of 1988.] **66.** (1) The Pharmacy and Drugs Act, 1988 is hereby repealed. (2) Notwithstanding the repeal effected by subsection (1), any Order, Rules, Notices or Regulations made under the repealed legislation and in force immediately before the commencement of this Act shall, unless revoked continue in force. FIRST SCHEDULE *(Section 1)* CLASS A DRUGS CLASS A PART I Acebutolol Acetazolamide (Diuretic Diamox) Acetophenaphtone Acetophenazine Acetyldihydrocodeinone Adicilline Baclofen Bamethan Sulphate Bendrofluazide Barbitone Barbitone Sodium Beazitramide No. 12 *Pharmacy and Drugs Act* 2001 35 Adrenocorticotrophic Hormone Aldosterone Algestone Acetophnide Allyloestrone Allyloestrenol Amikacin Amiloride HCI Aminoglutethimide Amiphenazole Amitriptyline Ammoniated Mercury Amoxycillin Amphomycin Amphotericin Amylase Amylobarbitone Androsterone Aprobarbitone Aprotinin Atenolol Atropine Sulphate Azacyclonol Hydrochloride Azapropazone Dihydrate Carfenazine Maleate Cefapirin sodium Cellulose Beclamide Beclomethasone Bemegride Benapryzine Hydrochloride Benoxaprofen Benperidol Benzoctamine Benzoestrol Benzquinamide Benzthiazide Betamethasone Betamethasone and its salts Bethanidine Sulphate Bromazepam Bromelains Bromodiphenhydramine HCI Brompheniramine Maleate Bufenine HCI Bumetanide Butaperazine Butazone Butriptyline Butobarbitone Calusterone Carbamazepine Carbaryl Carbenicillin Carbromal Carfecillin Carindocillin Sodium Carisoprodol Chlomedinone Chlormethiazone edysylate Chlomezanone Chlorproethazine 36 No. 12 *Pharmacy and Drugs Act* 2001 Cephacetrile Sodium Cephalexin Chlortriamsene Cephaloglycin Cephaloridine Cephazolin Chorionic Gonadotrophin Cephradine Chlorprothixene Chloracyzine Chloralformamide Chloral hydrate and Chloral Betane Chlorcyclizine HCI Chlordiazepoxide Chlorexolone Chlorhexadol Clonidine Hydrochloride Cloxacillin Codeine and its salts Corticotropin Corticotrophin Cortisone and its Salts Cyclandelate Cyclazocine Cyclobarbitone Calcium Cyclofenil Cyproterone Acetate Danazol Dantrolene Sodium Debrisoquine Dehydroprocestrone Demeclocycline Demethoxanate Deoxycortone Deoxycortone Acetate Deoxycortone Acetate and other Salts Chlorpromazine Chlorthalidone Chlortebol Acetate Chlortriamsene Cholic Acid Chymotrypsin Cinbocaine Hydrochloride Clindamycin Clobetasol Propionate and other salts' Clobetasol Propionate Clomiphene Citrate Clomocyline Sodium Clonazepam Clorazepate Codeine Phosphate Colistin Corticosteroids Cortisone Creosote Cyclarbamate Cyclobarbitone Cycloestrol Cyproheptadine HCI Dibenzepin Dichlorodifluoromethane Dichloralphenazone Diclofenac Sodium Dicloxacillin Dienoestrol Diethylpropion Diethylstilbestrol Diflunisal Dihydrogestrone No. 12 *Pharmacy and Drugs Act* 2001 37 Deserpidine Desipramine Desmopressin Desonide Dexamethasone Dexamethasone and its Salts Dexamphetamine and its Salts Dexchlorpheniramine Maleate Dextrimethorphan Hydrobromide Dorheipin Dextoromoramide Dextromoramide and its Salts Dextrompheiramine Maleate Dextropropoxyphene Napsylate Dextropropoxyphene Hydrochloride and other Salts Diazepam Diazoxide Epicillin Ergometrine Maleate Ergotamine Tartrate Erythromycin Erythromycin Ethylsuccinate Erythromycin Stearate Ethacrynic Acid Ethamivan Ethchlorvynol Ethinamate Ethisterone Ethosuximide Ethotoin Ethylcestrenol Ethynodiol Acetate Ethynodiol Diacetate Ethinyloestradiol Etonitazene Etoxeridine Eurethidine Diiodohydroxyquinoline Dimefline Hydrochloride Dimethindine Dimethisterone Diphenoxylate Hydrochloride Dipyoanone Hydrocholride Dipyridamole Doxapram Hydrochloride Dorheipin Hydrochloride Doxycycline Droperidol Drostanolone Propionate Domperidone Felypressin Fenbufen Fencamfamin HCI Fenclofenac Fenfluramine Fenoprofen Feprazone Flucloxacillin Fludrocortisone Fludrocortisone and its Salts Flufenamic Acid Flugestone Acetate Flumedroxone Acetate Flumethasone Fluocinolone Fluocortolone Pivalate Fluopromazine Fluoxymestrone Fluoxymesterone Flupenthixol Fluerolone 38 No. 12 *Pharmacy and Drugs Act* 2001 Extract Suprarenal Cortex Gamma Benzene Hexachloride Gestronol Hexanoate Glutethimide Glycine Gramicidin Guanethidine Halcinonide Heptabarbitone Hexobarbitone Human Albumin Hormone Human Luteinising Hormone Hydrocortisone Hydrocortisone and its Salts Hydroxyperhidine Hydroxyprogesterone Hydroxyzine Hyoscyamine Sulphate Ibomal Ibuprofen Idoxuridine Imipramine Indapamide Indomethacin Inositol Nicotinate Fluphenazine Flurazepam Flurandenolone Flurbiprofen Fluprednisolone Flurothyl Formaldehyde Fosfestrol (Diethylstilbestrol) Fluspiritene Fusidic Acid and its salts Gentamicin Gestronol Hexanoate Glyceryl Trinitrate Gonadorelin Growth Hormone Guanoxan Sulphate Haloperidol Hetacillin Hexoestrol Human Follicle Stimulating Hydroceotamate Hydrochloride Hydrocortisone Acetate Hydrargraphen Hydroxyphenamate Hydroxyprogesterone decanoate Hyoscyamine Hydrobromide Iprindole Hydrochloride Iproniazid Phosphate Isocarboxazid Isomethadone Isosorbide Dinitrate Isoxsuprine HCI Intermediate Acting Allobarbitone Iogonine and any Derivative of Ergonine which is convertible to Ergonine or to Cocaine No. 12 *Pharmacy and Drugs Act* 2001 39 Kaloid Ketazolam Labetalol Leptazol Levopropoxyphene Levorphanol Tartrate and other Salts Lidofiazine Lipase Lithium Litheronine Lobelia Lorazepam Lymecycline Lypressin Malathion Maprotiline Hydrochloride Mazindol Mebanazine Mebutamate Mecamylamine Medazepam Medicinal Opium and its Salts Medofenoxate hydrochloride Medrogestrone Medroxyprogesterone Medroxyprogesterone Acetate Medrysone Mefenamic Acid Megestrol Melanocyte Stimulating Hormone Melanostatin Mephenesin Meprednisone Meprobamate Mercuranade Mesoridazine Mesterolone Mestranol Metazocine Kanamycin Kitasamycin L-Cysteine Levomethorphan Levonorgestrel Lincomycin Lignocaine Hydrochloride Lincomycin HCI Lithium Carbonate Lividomycin Loxapine Luthutrim Lynoestrenol Methalleoestril Methallenestril Methalleoestrol Methandriol Metharbitone Methicillin Methocarbamol Methionine Methotrimeperazine Methoserpidine Methsuximide Metoprolol Metofoline Hydrochloride Metopam Methylergometrine Maleate Methylchlorthiazide Methyldestorphine Methyldihydromorphine Methylpentynol Methylphenidate Hydrochloride Methylprednisolone and its Salts Methylphenorpobotone Methylsulphonal Methyltestosterone 40 No. 12 *Pharmacy and Drugs Act* 2001 Methacycline Methadone Hydrochloride Minoxidil Morphine and its Salts Nadolol Naftidrofuryl Oxalate Naproxen Neoarsphenamine Nicocadeine Nicmorphine Nitrazepam Norethisterone Acetate Norethynodrel Norgestrel Nortriptyline Hydrochloride Oestriol Oestradiol and its Salts Oestradiol Oestrone Oleandomycin Opipramol Hydrochloride Opium and its preparations Orphenadrine Citrate Oyoscapine Oxacillin Oxandrolone Oxanamide Oxazepam Oxpentifyllin Oxprenolol Oxycodone Hydrochloride Oxymetholone Oxymorphone Hydrochloride Oxytocin Pancreatin Paraldehyde Paramethasone Acetate Pecazine Muncycline Minocycline Morpheridine Myrophine Nafcillin Nealbarbitone Nialamide Nicofuranose Nicotinyl Alcohol Nitrorazone Noracymethedol Pemoline Penamecillin Penfluridol Penicillamine Pentazocine and its Salts Penthrichloral Pentobarbitone Pentobarbitone Sodium Pepsin Perazine Pericyazine Perphenazine Pentaerythritol Tetranitrate Pethidine and its Salts Phenadoxone Hydrochloride Phenaglycodol Papaveretum Paramethadione Pargyline No. 12 *Pharmacy and Drugs Act* 2001 41 Phenatine Phenazocine Hydrobromide Phenbutrazate HCI Phencyclidine Hydrochloride Phendimetrazine Salts Phenelzine Phenetamine Phenaturide Phenmetrazine Phenol (Potaba) Phenobarbitone Phenobarbitone Sodium Phenoperidine Hydrochloride Phenoxybenzamine Phenprobamate Phensuximide Phentolamine Phenylmethylbarbituric Acid Phenylephrine Salts Phenytoin Sodium Pholcodine Piminodine Esylate Pimozide Pindolol Prolactin Promethcestrol Propiomazine Prothipendyl Protirelin Quinalbarbitone Quinestradol Quingestanol Acetate Racemethorphan Reserpine and Alkaloids of Rauwolfia Rifamycin Secbutobar[illegible]itone Sodium Serum Gonadotrophin Pipamazine Pipamperone Piperacetazine Piperazine Oestrone Sulphate Pipothiazine Piritramide Piroxicam Pivampicillin Polyoestra Potassium P-aminobenzoate Powdered Pituitary Prednisoamate Prednisolone Prednisolone and its Salts Prednisone Prednisone and its Salts Prednylidene Prenylamine Lactate Prethcamide Primidone Pristinamycin Prochlorperazine Progesterone Promazine Propranolol Prothipendyl Hydrochloride Protryptiline Quinalbarbitone Sodium Quinestrol Racemoramide Rifamide Rolitetracycline Nitrate Selenium Sulphide Sodium Aurothiomalate 42 No. 12 *Pharmacy and Drugs Act* 2001 Sodium Cromoglycate Sodium Valproate Spectinomycin Sulthiame Talampicillin Tamoxifen Testosterone and its Salts Testosterone Enanthate Tetrabenazine Thiamphenicol Thiopentone Sodium Thioridazine Thymoxamine Ticarcillin Tobramycin Tofenacin HCI Tolmetin Sodium Triacetyloleandomycin Triamcinolone and its Salts Trichlorofluoromethane Trifluperidol Trifluoperazine Trimetaphan Camsylate Triprolidine HCI Valnoctamide Verapamil Hydrochloride Vinbarbitone Yohimbine Hydrochloride Sodium Nitroprusside Sotalol Sulphonal Talbutal Testolactone Testosterone Tetracosactrin Thiethylperazine Thioproperazine Thiothixene Thyrotrophin Timolol Tocopheryl Acetate Tolazoline Tranylcypromine Triamcinolone Triamterene Triclofos Sodium Trimeperide Hydrochloride Trimeprazine Tartrate Trimipramine Tybamate Vasopressin Viloxazine HCI Viomycin CLASS A PART II—DRUGS NARCOTICS Acetydihydrocodeinone Allylprodine Alphacetylmethadol Alphameprodine Alphamethadol Alphaprodine Anileridine Benzathidine Levomethorphan Levomoramide Levophenocylmorphan Levorphanol Metazocine Methadone Methyldesorphine No. 12 *Pharmacy and Drugs Act* 2001 43 Betacetylmethadol Betameprodine Betamathadol Clonitazene Cocaine Dextromoramide Dextropropoxyphene Diamorphine Diampromide [N–(2 Methyl Phemethylaminopropyl) Propiondiolide Diethylthiambutene Dihydrocodeine Dimenoxadole Dimenphephthanol Dimethylthiambutene Dioxaphetyle Butyrate Diphenoxylate Dipipanone Ecgonine Ethylmotylthiambutene Ethylmorphine Etoxeridine Fentanyl Furethidine Hydrocodeine Hydromorphone Hydromorphinol Hydroxypethidine Isomethadone Kethbemidone Methadylacetate Methyldihydromorphine Mefoprolol Morpheridine Morphine Morphine Methobromide Morphine-N-oxide and other pentavalent nitrogens Morphine derivatives Myropine Nicomorphine Norcodeine Norlevorphanol Normethadone Normorphine Norpipanone Oxycodone Oxymorphone Pethidine Phenadoxone Phenazocine Phenomorphan Phenoperiodine Pholcodine Piminodine Propeptazine Properidine Racemethorphan Racemorphan Racelmoramide Thebaine Trimeperidine 4—Cyano-2, 2–dimethylamino–4, 4 diphenylbutane 1—Methyl–4–phenylpiperidine–4 Carboxylic Acid 1—Methyl–3–mospholino–1,1–diphenylpropanecarboxylic Acid 4—Phenylpiperidine-4-carboxylic acid ethylester 44 No. 12 *Pharmacy and Drugs Act* 2001 CLASS A PART III—SUBSTANCES USED IN THE MANUFACTURE OF NARCOTICS AND PSYCHOTROPIC DRUGS Acetic anhydride Acetone Anthranilic Acid Ephedrine Ergometrine Ergotamine Ethylether Hydrochloric Acid Isosafril Lysergic Acid Methylethyl ketone 3—methylenedioxyphenyl–2– propanone N—acetylanthranilic Acid Piperonal 1—Phenyl–2– propanone Piperidine Potassium permanganate Pseudoephedrine Safrole Sulphuric Acid Toluene CLASS B DRUGS Alumimum Chloride Aloes Alpha piperazine Hexahydrate Amoxycillin Trihydrate Ampicillin Benzathine Penicillin Benzylamine Hydrochloride Benzyl Penicillin Bisacodyl Butoxyethyl Nicotinate Calcium Sulphaoxalate Aloin Alphacillin Alverine Citrate Antazoline HCI BenzylBenzoate Bevonium Methylsulphate Bismuth Subgallate Camylofin HCI No. 12 *Pharmacy and Drugs Act* 2001 45 Carbenicillin Sodium Cascara Extracts Chloracidine Gluconate Chloramphenicol Caloropyrilene Citrate Chlorpheniramine Maleate Chlorthalidone Clemizole Undecanoate Clioquinol Clotrimazole Croton Oil Cyclopenthiazide Danthrone Dicyclomine HCI Dihydrocholic Acid Dihydrostreptomycin Sulphate Diisobutylphenoxypolyethoxy -ethanol Dimethylsulphoxide Diphenhydramine HCI Diphenylpyraline HCI Dithranol Triacetate Duclizine HCI Embramine HCI Ethinyloestradiol Ethynodioldiacetate Frangula Bark Fertility Thermometer Glycol Salicylate Hexachlorphane Hexamine Hippurate Hyaluronidase Hydrogen Peroxide Hydroxyquinoline Ichthammol Carbinoxaine Maleate Chlorophenoxyethanol Chlorobutol Chlordantoin Chlorphenesin Chlorquinol Cinnarizine Clemizole Cloponone Cloxacillin Cyclizine Dicophone Diethylamine Salicylate Dihydroxyacetone Dihydroxyaluminium Sodium Carbonate Dimenhydrinate Diperodon HCI Diphenoxylate dihydrochloride Dithranol Docusate Sodium Euonymus Ethylnicotinate Framycetin Furazolidone Hexachlorphane Hydrated m-Cresol Hydrochlorothiazide Hydroxychloroquine Sulphate (Plequanil) Intra-Uterine Devices (IUDs) 46 No. 12 *Pharmacy and Drugs Act* 2001 Ipecacuanha Ipomoea Resin Isphagula Jalap Jalapin Lactic Acid Loperamide Hydrochloride Meclozine Miconazole Methapyrilene HCI Methenamine Methylhydroxybenzoate Mepyramine Maleate Metronidazole Nalidixic Acid Nitrofurantoin Norethisterone Nystatin Octoxinol Oxyphenisatin Acetate Oxyphenonium Bromide Paromomycin Sulphate Penicillin V Sodium Phenindamine Phenacetin Phenoxyethanol Phosphoric Acid Piperazine Polymyxin Sulphate Potassuim Dichromate Pramoxine Hydrochloride Procaine Penicillin Promethazine Salsalate Sennoside A, B, C. Sodiumalkylsulphoacetate Isothipendyl HCI Jalapa Resin Levonorgestrel Lynoestrenol Melaleuca Oil MonoSulfiram Methdilazine HCI Methyclothiazide Methynicotinate Mestranol Myralact Neomycin Sulphate Nitrofurazone Nonoxynol–9, 10 and 11 Nonylic Varillylamide Norethisterone Acetate Norgestrel Oxolinic Acid Oxyphenisatin Acetate Oxytetracycline Pecilocin Penicillin G Pheniramine Maleate Phenolphthalein Phenoxypropanol Phthalysulphathiazole Podophyllum Polythiazide Potassuim. Hydroxyquinidine Sulphate Prepared Coal Tar Proflavine HCI Senega Sodium Acid Phosphate Sodium Benzoate No. 12 *Pharmacy and Drugs Act* 2001 47 Sodium Citrate Sodium Picosulphate Squill Succinylsulphathiazole Sulphadiazine Sulphafurazole Sulphametrole Sulphamethiazole Sulphathiazole Sulphurated Potash Terizodone Tetracycline Thiamphenicol Triclocarban Trimethobenzamide HCI Trioxsalen Tyrothricin Vaginal Contraceptive Cap Vancomycin Sodium Lauryl Sulphate Spiramycin Streptomycin Sulphacetamide Sulphadimidine Sulphaguanidine Sulphasalazine Sulphathiocarbamide Terpin Hydrate Tetrahydrofurfuryl Salicylate Tinidazole Triclosan Trimethoprim Tripelennamine HCI Vaginal Contraceptive Diaphragm CLASS C DRUGS Acetic Acid Agar Amino Acid Benzylkonium Chloride Bran Cade Oil Ceratonia Dextrose Fig Iron Compounds Kaolin Liquid Paraffin Magnesium Sulphate Methylcellulose Oil of Eucalyptus Olwoewain Capsicum Pectin Potasium Chloride Alcohols Acetylsalicylic Acid Attapulgite Boric Acid Calcium Phosphate Citric Acid Electrolytes Enoxolone Glycerol Lauromacrogol-4 Liquorice Menthol Methylsalicylate Oleic Acid Oleyl Alcohol Peru Balsam Precipitated Sulphur 48 No. 12 *Pharmacy and Drugs Act* 2001 Psyllium Sorbic Acid Sodium Chloride Sorbitol Sterculia Sweeteners Coal Tar Thymol Sodium Bicarbonate Sodium Oleate Starch Sulphur Terebenethine Trace Elements Vitamins Zinc Oxide SECOND SCHEDULE *(Section 35)* DISEASES IN RESPECT OF WHICH ADVERTISEMENTS ARE PROHIBITED Alcoholism Appendicitis Arteriosclerosis Asthma Blood Disorders Cancer Cataract Diabetes Cholera Diphtheria Disorders of Menstrual Flow Disorders of Prostate Gland Dysentery Encephalitis Enteric Fever Epilepsy Erysipelas Filariasis Gallstone, Kidney stones Bladder-stones Gangrene Glaucoma Goitre Genito–Urinary Diseases Hay Fever Obesity Onchocerciasis Palsy Paralysis Plague Pneumonia Poliomyelitis Rabies Rheumatic Fever Schistosomiasis Sexual Impotency Sexually Transmitted Infections Sterility Sleeping Sickness Smallpox Snake Bite Tetanus Trachoma Tuberculosis Tumours Typhoid Fever Ulcers Yaws Yellow Fever No. 12 *Pharmacy and Drugs Act* 2001 49 Heart Diseases Hernia High Blood Pressure Hepatitis Influenza Jaundice Kidney Disease Leprosy Locomotor Ataxis Measles Mental Conditions Mumps Nervousness Nutritional Disorders. PASSED in Parliament this *23rd* day of *October*, in the year of our Lord two thousand and one. J. A. CARPENTER, *Clerk of Parliament.* THIS PRINTED IMPRESSION has been carefully compared by me with the Bill which has passed Parliament and found by me to be a true and correctly printed copy of the said Bill. J. A. CARPENTER, *Clerk of Parliament.* PRINTED AND PUBLISHED BY THE GOVERNMENT PRINTING DEPARTMENT, SIERRA LEONE. *GAZETTE* NO. 58 OF 13TH DECEMBER, 2001.